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ABSTRACT: Discomfort is an unavoidable part of electrodiag-
nostic (EDX) studies. The most readily modifiable mediator of
electromyography (EMG)-associated pain is muscle selection.
Interventions that may reduce pain include vapocoolant spray,
ibuprofen, and techniques such as slapping or stretching the
skin. Needlestick injuries to health care workers carry the risk
of transmitting bloodborne illnesses, but other infectious compli-
cations of EDX studies are very rare. EMG probably contributes
to asymptomatic hemorrhage in approximately 1% of patients,
but clinically significant bleeding has only been reported a few
times. Therapeutic anticoagulation does not significantly
increase this risk. With standard procedures, there have been
no reports of patients developing cardiac arrhythmia from nerve
conduction studies. No special precautions are necessary in
patients with implantable cardiac devices or intravenous lines.
There is a small risk of pneumothorax associated with EMG of
the diaphragm and chest wall muscles. Several techniques
have been suggested to improve the safety of diaphragm EMG.
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Electrodiagnostic (EDX) studies are useful in the
diagnosis and characterization of neuromuscular
disorders.1 Potential complications of EDX studies
include discomfort, transmission of infectious dis-
ease, cardiac arrhythmia, hemorrhage, and pneu-
mothorax. By understanding these complications,
EDX consultants can take appropriate precautions
to prevent them.
PAIN
Importance of Electromyography-Related Pain. Pain
is the most common complication of nerve con-
duction studies and needle electromyography
(EMG). Some studies suggest that needle EMG is
the more painful of the 2 procedures.2–5 The EDX
consultant must study the correct muscles to
address the diagnoses in question and study each
muscle for sufficient time to identify relevant
abnormalities.6 Pain is often cited as a cause of
incomplete or inconclusive EDX studies. In a sur-
vey of over 800 EDX consultants, 60.1% reported
altering> 10% of their needle examinations due
to the perception of patient pain.7 These altera-
tions include avoiding certain muscles, spending
less time studying muscles, or even aborting the
study prematurely. Altering studies may protect
patients from additional discomfort, but doing so
comes at the cost of disregarding the physician’s
judgment about what constitutes an appropriate
and complete study and potentially reduces the
diagnostic accuracy of the test.
In an observational study, physicians altered
almost one-third of studies because of their per-
ception of patient pain.8 The greater the
physician-estimated level of patient pain, the great-
er the chance that the study would be altered in
some way. Patient-reported pain levels did not cor-
relate with the risk of studies being altered. This
suggests that EDX consultants are not good at
gauging patient pain levels. Studies are conflicted
about whether physicians tend to overestimate or
underestimate pain.8,9 It is possible that physicians
are attending to the limb or the digital display dur-
ing the procedure, and therefore miss nonverbal
indicators of pain severity, such as facial expres-
sion. Regardless, it is the physician perception of
pain, rather than the actual patient pain, that leads
to altered studies.8 One way to reduce unnecessary
alteration of studies is to align physician and
patient perceptions of pain by improving commu-
nication Having patients rate their pain through-
out the study would accomplish this goal. At the
same time, the physician should update the patient
regarding the relative clinical value of additional
diagnostic testing. This empowers patients to
request that the study by altered or aborted when
doing so would not substantially compromise the
diagnostic yield of the EDX study. In this way,
increased doctor–patient communication may not
only limit pain, but reduce wasted time and low-
yield testing.
It is the author’s experience that concern about
needle-related pain leads some patients to post-
pone or forego potentially useful EDX testing, but
we do not know how often this happens. Fortu-
nately, studies have suggested that needle EMG is
less painful than patients expect, and the majority
of patients who undergo EDX studies report will-
ingness to have the test performed again.10 In a
survey of children, 66% of subjects reported that
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needle EMG-related pain was equivalent or less
than venipuncture.11
Factors Contributing to EMG-Related Pain. The level
of pain that patients experience during EDX test-
ing may be related to patient-level factors,
physician-level factors, and study-level factors. In 1
analysis, patient characteristics accounted for 47%
of the variance in patient pain.12 Most likely, this is
driven by psychosocial factors that are difficult to
measure, such as “pain tolerance.” It is known that
pre-existing anxiety predicts EMG-related pain.13,14
Patients with high levels of baseline pain and dis-
ability from their underlying illnesses report more
EMG-related pain, as well.15 Studies are conflicted
about whether women experience more EMG-
related pain than men.2,16 There is a small, but sig-
nificant correlation between expectation of pain
and EMG-related pain.12 Self-identified Asians may
experience more pain than other individuals. Oth-
erwise, age, height, weight, race, ethnicity, and pri-
or history of EMG do not seem to affect pain
levels.12 Physician-level factors, such as years of
experience or whether the EDX consultant is a
neurologist or physiatrist have very little effect on
pain.12
Of course, factors related to the demographics
of the patient and physician may not be relevant,
because they cannot be controlled or modified. A
prospective study of 227 patients suggest that nee-
dle examination of the abductor pollicis brevis was
more painful than the first dorsal interosseous of
the hand.16 Among study-level factors that the
EDX consultant can control, the choice of muscles
has the greatest impact on pain. In another study,
304 patients rated their pain on a visual analog
scale after each muscle was studied. Among the
1781 muscles studied, the choice of muscle
accounted for nearly 50% of the variance in
pain.12 The authors of this study calculated adjust-
ed pain scores for every muscle examined, correct-
ing for the amount of time in each muscle,
whether endplate noise was detected, the order
the muscle was studied, and patient-level character-
istics. These scores represent the adjusted marginal
pain on a 100 mm visual analog scale. The most
painful muscles were the rectus femoris, extensor
digitorum brevis, abductor hallucis, extensor hallu-
cis longus, abductor pollicis brevis, opponens polli-
cis, vastus lateralis, medial gastrocnemius, and
thoracic paraspinal muscles. The least painful
muscles were the deltoid and gluteus medius.
One possible application of these scores would
be in screening for radiculopathy. It has been rec-
ommended that needle examination should
include 5 limb muscles and a paraspinal muscle
when screening for cervical or lumbar
radiculopathy.17,18 The authors suggested various
protocols, each of which had a similar sensitivity
for the diagnosis of radiculopathy. It is possible to
summate the average marginal pain scores associat-
ed with all of the muscles in each of these proto-
cols to identify the least painful cervical and
lumbar root screens. Using this method, the rec-
ommended cervical root screen includes the del-
toid, triceps, extensor digitorum, first dorsal
interosseous of the hand, flexor carpi ulnaris, and
a cervical paraspinal muscle. The least painful lum-
bar root screen includes the tensor fascia latae,
posterior tibialis, anterior tibialis, vastus medialis,
lateral gastrocnemius, and a lumbar paraspinal
muscle.
The type of needle electrode used may also
affect pain severity. Earlier studies suggested that
monopolar needles, which are thinner and cause
less tissue damage are less painful than concentric
needles.19,20 More recent studies showed no signifi-
cant difference between the 2 types of needle elec-
trodes.9,21 The order in which muscles are studied
and the amount of time spent with the needle in
each muscle do not have meaningful effects on
patient pain levels.12
Insertion of the needle electrode into the motor
endplate region of the muscle leads to greater lev-
els of pain. Pain at the endplate region was insignif-
icantly greater than the pain associated with skin
penetration. The quality of the pain was no differ-
ent in the endplate region than in electrically silent
muscle. This is another study-level characteristic,
but the EDX consultant has little control over it.
The etiology of increased pain at the motor end-
plate is unknown, but one proposed theory is that
pain fibers are more densely situated in this region.
Another possibility is that the needle provokes
enough depletion of acetylcholine from the presyn-
aptic membrane to generate an axon potential.
This causes the muscle to contract, and the move-
ment of the fiber irritates the nearby pain fibers.22
Interventions to Reduce Pain. Investigators have
proposed several interventions to reduce EMG-
related pain. One study compared vapocoolant
spray (ethyl chloride, or a similar substance that
acts as a skin refrigerant), EMLA cream (eutectic
mixture of local anesthetics), and placebo in nee-
dle examination of the medial gastrocnemius.23
The vapocoolant spray was significantly better than
placebo in reducing EMG-related pain. The EMLA
cream was no different from placebo. It is unclear
if cooling the skin in this manner affects the inter-
pretation of the needle examination. If the vapo-
coolant spray indirectly cooled the muscle, it
could, increase the amplitude, duration, and
phases of motor unit action potentials.24
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A crossover study compared the analgesic
effects of ibuprofen to placebo in subjects who
were to undergo needle examination of a proximal
and distal muscle in the upper and lower extremi-
ty. The subjects who took 400 mg of ibuprofen 2 h
before the EMG reported less pain on immediate
recall, but there was no difference in the delayed
recall of pain or residual pain. Subgroup analysis
showed a greater effect in women than men, but
there were only 7 women in the study.25
In a crossover study of 44 healthy volunteers,
pain immediately after needle EMG was significant-
ly less in patients who took paracetamol (acetamin-
ophen) 325 mg/tramadol 37.5 mg than those in
the placebo group. Two hours after the EMG, men
in the treatment arm continued to report signifi-
cantly less pain than those in the placebo arm, but
there was no difference between women in the
treatment and control groups.26 While these
results were encouraging, the incidence of adverse
effects was much higher in the treatment group
than the placebo group. In addition to many sub-
jects in this small study who reported minor
adverse events, 1 subject had a syncopal episode
after taking acetaminophen/tramadol, and anoth-
er developed severe vertigo requiring hospitaliza-
tion. The incidence and severity of adverse events
is probably too high to justify routine use of this
medication combination without further study.
Another crossover study found evidence to sup-
port slapping the patient’s skin at the time of nee-
dle insertion.27 This finger-slapping technique has
been used by Korean nurses to reduce the pain
associated with venipuncture.28 It is based on the
gate control theory of pain, that afferent impulses
in large mechanoreceptor nerve fibers inhibit
impulses from smaller nociceptive nerve fibers.
Stretching the skin before needle insertion may
also decrease the pain of needle EMG.29
A minimal insertion technique appears to
reduce pain, as well.9 This entails a needle move-
ment of 0.5–1 mm per insertion, causing less than
200 ms of insertional activity.
Several other interventions to reduce pain have
been touted, including lidocaine iontophoresis,
hypnosis, acupuncture, behavioral modification,
and relaxation techniques, providing patients with
written material describing the procedure ahead of
time, and having patients listen to music on head-
phones.3,30–35 Most of these are smaller studies
with underwhelming results, and many of the
interventions require special expertise or are too
time-consuming to use in routine practice.
Pain Associated with Nerve Conduction
Studies. Other studies have suggested that there
may be more pain associated with nerve
conduction studies than with needle EMG.4 This
appears to be a larger effect among older patients
and those with a greater body mass index.5 No
studies have been done on interventions to reduce
the pain associated with nerve conduction studies.
INFECTION
Skin Infections and EMG Needles. Skin infections
are a very rare medical complication of needle
EMG. A series of 6 patients were reported who
developed Mycobaterium fortuitum skin infection fol-
lowing EMG. However, this was in the setting of
reusable needles cleaned with glutaraldehyde and
rinsed with tap water.36 There is a single reported
case of Staphylococcus epidermidis cellulitis following
EMG.37 It is unknown whether the skin was pre-
pared with alcohol, or what type of needle was
used. This case was reported in 1986, at a time
when reusable needles were more commonly
employed. It is unlikely that standard EDX proce-
dures with single-use needles present a significant
risk factor for skin infections in the general popu-
lation. Reusable needles, such as those used for
single-fiber EMG, must be sterilized between
patients according to Joint Commission Accredita-
tion Healthcare Organizations standards.
Many EDX consultants use what has been
referred to as “clean technique” during EMG. This
means that they wash their hands before each
study, wear gloves, and clean the patient’s skin
with an alcohol preparation immediately before
needle insertion. This practice most likely reduces
the number of microorganisms on the skin, but
there is no evidence that it prevents iatrogenic
skin infection. Uncleaned skin has approximately
2.03 104 colony-forming units of Staphlococcus aure-
us. It takes 7.53 106 colony-forming units of S.
aureus injected intradermally to cause an abscess.38
Although there is a lack of data pertaining spe-
cifically to the benefits of skin preparation in elec-
trodiagnosis, it is reasonable to equate EMG with
subcutaneous insulin injections. In a small pro-
spective study, patients who injected themselves
with insulin and did not prepare the skin with
alcohol showed no signs of local or systemic infec-
tion.39 In a large retrospective cohort of diabetic
subjects who gave themselves an estimated 10 mil-
lion insulin injections, the incidence of cellulitis
was actually greater in subjects who wiped their
skin with isopropyl alcohol than those who did
not.40
Based on these findings, the practice of prepar-
ing skin with an alcohol wipe before needle EMG
is superfluous. Of course, if skin is visibly infected,
it is prudent to clean the skin or avoid needle
insertion through the site of infection altogether.
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Precautions to Prevent Transmission of Disease
between Healthcare Workers and Patients. Human
immunodeficiency virus, hepatitis B virus, and oth-
er bloodborne pathogens may be transmitted
through contact with open wounds, mucus mem-
branes, or body fluids such as blood. Needle EMG,
like any procedure that involves sharps, carries
some risk of bloodborne infection. It is important
to take appropriate measures to reduce the risk of
transmitting bloodborne pathogens from patients
to EDX consultants and staff, from EDX consul-
tants and staff to patients, and from EDX equip-
ment to either party.
In 1983, the Centers for Disease Control and
Prevention (CDC) issued its first guideline calling
for blood and body fluid precautions when dealing
with patients known to be infected with blood-
borne pathogens. In 1987, the CDC updated these
recommendations to include all patients. These
universal precautions, now called standard precau-
tions, are mandated by the Occupational Safety
and Health Administration (OSHA) and are
among the most effective ways health care workers
can protect themselves and their patients against
exposures.41,42
Health care workers should wear gloves to pre-
vent transmission of bloodborne pathogens.43–45
Following needlestick with a solid-bore needle,
gloves reduce the risk of disease transmission by
46–86%.46 Latex and nitrile gloves are more effec-
tive than vinyl gloves.47–49 The American Associa-
tion of Neuromuscular and EDX Medicine
(AANEM) recommends that gloves be worn when
the possibility of contact with blood and other
potentially infectious materials exists during needle
EMG.50 However, not all EDX consultants follow
this recommendation. In a 2008 survey of AANEM
members, 73% of respondents reported that they
always wore gloves, and 11% reported that they
never wore gloves.51 It is unknown if the rate of
glove-wearing has changed in the years since this
survey.
During needle EMG, the EDX consultant
should avoid touching anything other than the
patient and the EDX equipment. If visible blood
gets on equipment, it should be disinfected
between patients. It may be necessary to change
gloves in the midst of a single encounter if the
patient interaction involves touching mobile com-
puter keyboards or other mobile equipment that is
taken from room to room.52 Gauze with blood on
it should be placed in disposal containers that
meet OSHA standards. Physicians and staff should
dispose of all waste in accordance with all federal,
state, and institutional regulations. Personal pro-
tective equipment such as gloves should be
removed prior to leaving the examination room
and placed in an appropriately designated contain-
er for disposal.
Needlestick Injuries. In a survey of AANEM mem-
bers, 64% of responders reported a personal histo-
ry of at least 1 needlestick injury.51 Most
needlesticks reported by EDX consultants occurred
in the course of routine procedures, but patient
movement and recapping were cited as common
causes. Recapping needles with a one-handed tech-
nique rather than holding the cap in 1 hand dur-
ing recapping may reduce needlestick injuries.
More concerning is that 33% of those surveyed
were not aware of their lab’s or institution’s poli-
cies for dealing with needlesticks, 56% had never
had a needle safety component of their EDX medi-
cine training, and 44% did not report their injury
to official hospital health centers.51
Needlestick injuries have been implicated in
transmission of bloodborne infections such as hep-
atitis and human immunodeficiency virus (HIV)
from patients to healthcare personnel.53 Fortunate-
ly for EDX consultants, the risk of transmission is
much lower with solid-bore needles such as those
used in EMG than hollow-bore needles.54 Taking
appropriate action following a needlestick injury
can further reduce the risk of infectious transmis-
sion. Health care workers should immediately
remove protective gloves and wash the injured area
thoroughly with soap and water. Every institution
should have a process in place for reporting the
incident, and testing the patient for HIV, hepatitis
C antibody, and hepatitis B surface antigen. The
turnaround time for these tests is usually a day or
less.55,56
At-Risk Patient Populations. Some populations of
patients may be at special risk for contracting
infections. Patients with breast cancer, pelvic can-
cer, or melanoma may develop lymphedema fol-
lowing diagnostic or therapeutic lymph node
dissection. Historically, patients are cautioned
against having venipuncture in the affected limb to
avoid development or worsening of lymphedema
or cellulitis. The theoretical concern is that needle-
sticks in the affected limb could cause an inflam-
matory reaction that could overburden an already
compromised lymphatic drainage route. The evi-
dence to support the practice of avoiding veni-
puncture is controversial. In a study of 691
referrals to a lymphedema service, 10 patients
(1.5%) cited venipuncture as a significant event in
the history of their swelling.57
In a prospective observational study of 188
lymphedema patients, 44% of those who were sub-
jected to needle sticks developed lymphedema as
compared to 18% of those without needle sticks.58
Other authors suggest that there is no reason to
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avoid needlesticks, citing other studies that showed
few, if any, patients with lymphedema developed
increased swelling following venipuncture.59,60
These studies are challenging to interpret in their
intended clinical contexts, and even more chal-
lenging in the context of needle EMG. There are
no reported cases of cellulitis or increased swelling
following EDX studies in this population. A reason-
able approach is first to attempt to address the
EDX questions by studying a limb that is not affect-
ed by lymph node dissection. If that is not feasible,
the EDX consultant and patient should weigh the
relative diagnostic value of the study against the
small theoretical risk of developing lymphedema.
EDX patients with diabetes may have poor
wound healing and a greater risk of infectious
complications. While diabetic patients have been
known to develop foot ulcers following needle-
induced trauma, it is unknown if needle EMG
poses a risk to diabetic patients.61 It is reasonable
to exercise caution and avoid needle examination
of intrinsic foot muscles in patients with severe
diabetes.
Patients with a history of valvular heart disease
do not require prophylactic antibiotics before nee-
dle EMG. While there is a theoretical risk that
patients with prosthetic joints may develop joint
infection from hematogenous spread, there are no
reported cases of this occurring as a result of nee-
dle EMG. Again, prophylactic antibiotics are not
recommended.62
BLEEDING
Bleeding complications secondary to needle
EMG are very rare among patients with no history
of medically induced anticoagulation. There are 2
case reports of patients who developed compart-
ment syndrome in a limb following EMG.63,64 One
of the hematomas was traced to unintentional lac-
eration of the ulnar artery, and the other was sus-
pected to be caused by damage to a perforating
vessel from the posterior tibial artery.
In 1996, Caress et al. reviewed spine MRI scans
of patients who had undergone paraspinal EMG
within the prior week.65 Five of the 17 patients in
this series were found to have asymptomatic hema-
tomas in or around the sampled paraspinal
muscles. Follow-up studies, however, have not
reproduced this finding. In a retrospective review
of 431 patients who underwent spine MRI within a
week of EMG, no hematomas were noted.66 In
another study, a blinded radiologist compared the
MRI scans of 29 patients who underwent recent
extensive paraspinal EMG using the paraspinal
mapping technique to the MRI scans of 26 control
patients who had not had a recent EMG. In both
the study and control groups, there were a similar
number of “possible” hematomas, in which lesions
lacked a hemosiderin ring and were behind or
immediately contiguous to facet joints. The radiol-
ogist could not determine whether these repre-
sented small hematomas or synovial cysts arising
from degenerative facet joints. Surprisingly, the
only 2 definite hematomas identified were in the
paraspinal muscles of control subjects. None of the
definite or possible hematomas were larger than
10 mm, and none were near any neural
structures.67
Most of the patients in the aforementioned
studies were not taking medications that could
increase the risk for bleeding following instrumen-
tation. In 1999, the AANEM issued a position state-
ment which recommended exercising caution
when deciding whether to perform needle EMG
on patients with platelet counts less than 50,000/
ml, an international normalized ratio (INR)> 1.5–
2.0, or prothrombin time >1.5–2.0 s.50 The posi-
tion statement also recommended a number of
practice modifications to reduce the risk of hemor-
rhage if the EDX consultant chooses to perform
an EMG on one of these patients.
These recommendations were not based on any
controlled studies and did not take into account
many of the other medications known to affect
coagulation. This includes the newer oral agents
(dabigatran, apixaban, rivaroxaban), intravenous
and subcutaneous anticoagulants (heparin, dalte-
parin, enoxaparin), antiplatelet agents (aspirin,
aspirin/dipyridamole, clopidogrel), and nonsteroi-
dal anti-inflammatory drugs. Despite the wide-
spread use of these medications, there have been
very few reported cases of clinically significant
EMG-induced bleeding complications in this popu-
lation. One patient who was taking chronic warfa-
rin therapy developed anemia and ecchymosis on
his flank following an EMG. Complicating this case
was the observation that the subject had fallen on
the same side of his body 2 days previously.68 Simi-
larly, a patient who had suffered from a recent
back injury and was receiving heparin and aspirin
developed paraspinal and iliopsoas hematomas fol-
lowing EMG.69 In both of these cases, it is not
clear if there was truly a causal relationship
between the EDX study and the hemorrhagic com-
plications. The third reported case was a patient
on warfarin with an INR of 2.5 who developed a
posterior tibial pseudoaneurysm which was man-
aged conservatively.70 The final reported case was a
patient taking aspirin and subcutaneous heparin
who developed a large gluteal hematoma.71 This
patient was also found to have hematomas in other
locations and limbs that had not been examined
during the EDX study.
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The actual incidence of symptomatic EMG-
induced hemorrhage in anticoagulated patients is
unknown, but in a survey of 60 EDX laboratories,
4 of 47 responders (9%) reported a history of at
least 1 clinically significant bleeding complication
from performing EMG in this population.72 A
majority of responders noted that they altered
their practices to account for the risk of anticoagu-
lation: 72% avoided EMG of paraspinal muscles;
34% avoided certain limb muscles; and 13%
required patients to withhold anticoagulation ther-
apy in anticipation of the study. Even though none
of the responders reported hemorrhagic complica-
tions with antiplatelet medications, 19% altered
their studies in some way in patients taking these
medications.
In 2008, investigators used ultrasound to screen
for hematomas in 209 patients who had just under-
gone needle EMG of the tibialis anterior. The
overall incidence of ultrasound-proven hematoma
was 1.45%, and there was no significant difference
between patients taking oral anticoagulants,
patients taking anti-platelet medications, and con-
trol patients.73 None of these patients reported
symptoms during the examination, and no men-
tion of symptomatic hematoma was found on chart
review 3–15 months later.
A follow-up study used ultrasound to screen for
post-EMG hematoma in 323 “high-risk” muscles,
including the paraspinal muscles, the tibialis poste-
rior, the flexor digitorum longus, the flexor polli-
cis longus, and the iliopsoas. The overall incidence
of hematoma among all muscles studied was
0.62%.74 One small hematoma was noted in 1 of
the 107 patients taking warfarin, and in 1 of 116
patients taking anti-platelet therapy, while no
hematomas were noted in 100 control patients.
Again, this was not a statistically significant differ-
ence, and none of the subjects reported symptoms.
Taken together, 10 definite hematomas have
been reported in 1,037 muscles that have been
imaged after EMG, with an absolute risk of less
than 1%. The risk was slightly higher (1.35%) in
therapeutically anticoagulated patients and slightly
lower (0.61%) among patients on anti-platelet
medications.75 Overall, the risk of asymptomatic
bleeding is very low in all groups, and the risk of
symptomatic bleeding is so rare that it has only
been reported a few of times in the many decades
of collective clinical experience with EMG. The
author’s recommendation is to do complete and
appropriate EDX evaluations on patients receiving
antiplatelet medications or those taking warfarin
with an INR< 3.0. Patients should not be asked to
withhold therapeutic anticoagulation prior to EDX
studies. In patients with an INR >3.0, the study
may be completed at the discretion of the EDX
consultant. If the managing physician intends to
lower the warfarin dose, it may be reasonable to
postpone the study until the INR is in the thera-
peutic range.
No data exist to guide our practice in patients
receiving therapeutic doses of heparin or oral anti-
coagulants other than warfarin. It is likely that
patients on therapeutic doses of these treatments
will have a similarly low incidence of EMG-induced
hemorrhage, but the actual risk is unknown. Like-
wise, little is known about the bleeding risks associ-
ated with herbal supplements, but it is unlikely
that they pose a greater risk than pharmaceutical
anticoagulants.
ELECTRICAL COMPLICATIONS OF NERVE
CONDUCTION STUDIES
The electrical currents used in nerve conduc-
tion studies are too small to directly damage tis-
sues, but the heart is an electrically sensitive organ.
Two hundred mA of current applied directly to the
myocardium is enough to induce ventricular tachy-
cardia,76 and yet, a current 5 times as large, 1 mA,
is barely perceptible on the skin, and certainly not
dangerous.
There are theoretical mechanisms by which
otherwise harmless electrical currents may reach
the heart. The first pertains to the concept of leak-
age currents. When electrical devices are attached
to a patient, a small amount of current may leak
from the internal electronics. Stray voltages can
also build up on power cords. The magnitude of
these voltages correlates directly with the length of
the cord. Extension cords, for instance, may accu-
mulate very high leakage currents which can find
their way to the patient.77 The third prong on a
standard electrical plug serves as a ground, allow-
ing stray currents to dissipate safely. One scenario
in which this system can fail is if a patient is
attached to electrical devices on both sides of the
body, and 1 of the grounds fails due to a frayed,
loose, or wet cord. Now the leakage current from
the device with the malfunctioning ground has
nowhere to go except across the patient’s body to
the contralateral ground. If the leakage current in
this scenario is sufficiently great, it could, in theo-
ry, be enough to induce arrhythmia.
Critically ill patients in an intensive care unit
are the most electrically susceptible, because they
are often connected to a number of electrical devi-
ces simultaneously. To minimize the potential risk
of leakage current, EDX consultants should ensure
that their equipment is appropriately grounded on
the same side as the stimulation. Extension cords
should not be used, and patients should be discon-
nected from all nonessential electrical equipment
prior to EDX studies. Machines should be turned
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on before attaching electrodes to patients and
turned off after removing the electrodes from the
patient to minimize the risk of power surges. Bian-
nual inspection of EDX equipment by a biomedi-
cal engineer to measure leakage current and
ensure proper grounding is prudent, as well.
Skin resistance is the body’s greatest defense
against all electrical injury. Intact skin confers sev-
eral million Ohms of resistance. Patients with a
transcutaneous pacer wire, on the other hand,
have a direct electrical conduit from the surface of
the skin to the heart. These patients are extraordi-
narily sensitive to electricity. Nerve conduction
studies should be avoided altogether in this
population.78
Peripheral intravenous access does not compro-
mise the protective effects of skin. One study
found no deleterious effects of performing nerve
conduction studies on patients with peripheral
intravenous lines in a distal limb. It did not matter
whether fluids were running through the line or
the line was clamped.79
Until recently, performance of nerve conduc-
tion studies in patients with central venous cathe-
ters in the internal jugular or subclavian veins was
controversial. These lines create a larger skin
breach than peripheral intravenous lines in the
distal limb. They also extend toward the heart,
bypassing the electrical sink provided by the soft
tissues of the torso. Some authors have suggested
ipsilateral or proximal nerve conduction studies be
avoided in patients with central lines.62 There is
evidence that these precautions are probably
unnecessary. In an unpublished study by the
author, 10 patients with and 10 patients without
central lines underwent nerve conduction studies
on both upper extremities, including proximal
and distal stimulation, high and low amplitude
stimulation, and 2 HZ repetitive stimulation. Sub-
jects underwent electrocardiographic monitoring
throughout the nerve conduction studies. No sig-
nificant arrhythmias or conduction abnormalities
were noted in either the control subjects or the
subjects with central lines.
Pacemakers and defibrillators are implanted
below the skin and, therefore, do not impact skin
resistance. The concern is that pacemakers have
electrical sensors that regulate their control of the
heart rhythm. Likewise, defibrillators have sensors
that are intended to recognize malignant arrhyth-
mias and discharge a large shock to reset the heart
rhythm. There is a potential danger if these devi-
ces were to discharge inappropriately. There are
no reported cases of patients developing failure of
implantable cardiac devices during routing EDX
studies, but there are reports of compromised
pacemaker function in dissimilar and unusual
scenarios. One case of pacemaker failure was in
the setting of an implanted phrenic nerve stimula-
tor and the other with a portable nerve stimulator
in the operating room.80,81
Three studies between 1988 and 2010 found
that pacemakers or automatic implantable
cardioverter-defibrillator (AICD) devices in a total
of 40 patients failed to sense nerve conduction
stimulations.79,82,83 In another study, subjects
under general anesthesia for device implantation
or revision were given 2 HZ and 50 HZ repetitive
stimulation of the median, axillary, and spinal
accessory nerves.84 The 10 AICD devices in this
study did not sense the exogenous currents. In the
subjects with pacemakers, the findings depended
on whether the device was set to a unipolar or a
bipolar configuration. The unipolar configuration
is an outdated modality in which the reference
electrode is placed on the chest wall instead of in
the heart. The larger distance between the 2 elec-
trodes makes the device more sensitive to far field
potentials. Modern pacemakers may be configured
this way, but it has not been the industry standard
for >25 years. In this study, pacemakers set to the
standard bipolar configuration did not sense the
nerve conduction stimulations. A subset of the
pacemakers set to the unipolar configuration
sensed some of the stimulations enough to alter
the pacing of the heart for the duration of the
impulse. This finding does not portend a realistic
risk to patients. Perhaps it is possible that a high
amplitude proximal repetitive stimulation in a
patient with a very old pacemaker could alter pac-
ing for 2–3 s. Even in this very rare scenario, most
patients would be asymptomatic or, at worst, devel-
op 2 to 3 s of lightheadedness.
Some pacemaker or AICD companies require
EDX consultants to place a “magnet” on the devi-
ces and monitor heart rhythm during nerve con-
duction studies. A magnet is thought to counteract
the electromagnetic interference from nerve con-
duction studies and eliminate the sensing compo-
nent of the device.85 Ohira et al. performed nerve
conduction studies in 30 patients after magnet
placement and 47 patients without magnet place-
ment. None of the stimulations were detected in
either group, but the subjects who had the magnet
placed were 11 times more likely to report symp-
toms such as scapular pain, chest pain, paresthe-
sias, or lightheadedness. Based on these data,
magnet placement is not recommended for EDX
testing in patients with implantable cardiac
devices.86
Deep brain stimulators (DBS) are used in
patients with Parkinson disease and other move-
ment disorders. They are implanted in the chest
wall, on either side of the pectoralis muscle, and
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have leads that travel rostrally through the neck
and skull to reach the deep nuclei of the brain.
There is no U.S. Food and Drug Administration
labeling for the combination of nerve conduction
studies and DBS, but it is unlikely that there would
be any interaction between them. DBS devices are
not programmed to sense electrical impulses the
way pacemakers do, so it is not possible to measure
if these devices detect nerve conduction stimuli.
A summary of recommendations for avoiding
infectious, hemorrhagic, and electrical complica-
tions of EDX studies can be found in Table 1.
PNEUMOTHORAX
Pneumothorax is a rare but serious complication
of needle EMG of the diaphragm, supraspinatus,
rhomboids, and cervical paraspinal muscles.87–92 A
telephone survey of 1,000 patients who had under-
gone EMG of the diaphragm identified 2 with symp-
tomatic pneumothorax, both of whom were
inpatients receiving mechanical ventilation at the
time of the complication.
A large retrospective study of 64,490 patients
identified 7 cases of pneumothorax associated with
EMG.93 Another 22 patients in this series were
found to have a pneumothorax that was temporally
associated with the EMG study, but it was believed
to be attributable to a different cause, such as a
recent lung biopsy or thoracentesis. The highest
frequency of EMG-induced pneumothorax in this
series was among patients who had undergone
EMG of the serratus anterior (0.445%) and the
diaphragm (0.149%). All patients who were found
to have pneumothorax were symptomatic and pre-
sented within 24 h.
A simple way to prevent these complications is
to avoid EMG of these muscles, but the diagnostic
utility of the study may outweigh the risk.94–96 In
the critically ill population, nearly 60% of neuro-
muscular diseases may be identified with EMG of
limb muscles alone, but an additional 30% remain
undetected unless respiratory muscles are
examined.97,98
Various techniques have been proposed to
reduce the risk of pneumothorax secondary to
EMG of the diaphragm. Bolton proposed what has
been called the “trans-intercostal method.” The
EDX consultant palpates the lower costal margin
and inserts a monopolar needle just above this
margin at the most distal palpable intercostal space
between the anterior axillary and medial clavicular
lines. No pneumothorax was identified in 49 con-
secutive patients, including 32 in the critical care
unit.99,100 Another author noted anecdotally that
using a concentric needle with a variant of this
method led to no pneumothoraces in 53 consecu-
tive pediatric cases.101
Saadeh et al. proposed an alternative tech-
nique, in which the abdomen is depressed with the
examiner’s nondominant hand to delineate the
costal margin. A 50 mm needle is inserted under
and behind the 9th rib cartilage, parallel to the
long axis of the body and closely hugging the pos-
terior aspect of the chest wall. The needle is
advanced to about 3.0–3.5 cm of depth to costal
insertion of the diaphragm. Eighty-nine patients
and 108 hemidiaphragms were studied without any
complications.102 In a letter to the editor many
years later, the authors reported anecdotally that
they have used this technique on thousands of sub-
sequent diaphragms without a complication.103
A study of cadavers suggested that the best
combination of safety and accuracy could be
achieved by inserting the needle perpendicular to
the chest wall directly above the eighth rib.104 The
side of needle placement made no difference in
accuracy, but the left side appeared to be safer.
The use of ultrasound has increased our under-
standing of anatomic localization. Using this
Table 1. Populations at risk for complications of EDX studies
Potential complications Recommendations
Infectious
History of lymph
node dissection
Consider avoiding needle
examination in affected
limb
Severe diabetes mellitus Consider avoiding needle
examination of intrinsic
foot muscles
Valvular heart disease No precautions necessary
Prosthetic joints No precautions necessary
Bleeding
On anti-platelet therapy No precautions necessary
On warfarin therapy If INR<3.0, no precautions
other than close surveil-
lance during and imme-
diately after needle EMG.
If INR>3.0, exercise
caution
On heparin or other oral
anticoagulant
No precautions are likely to
be necessary at thera-
peutic doses, but risks
are unknown
Electrical
Transcutaneous pacemaker Do not perform nerve con-
duction studies
Peripheral or central
intravenous line
No precautions necessary
Patient in critical care unit Properly ground equipment
on the side of the study
Do not use extension
cords
Implanted pacemaker
or defibrillator
No precautions necessary
DBS No precautions necessary
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modality, Shahgholi et al., demonstrated that the
location of diaphragm below the surface of the
skin varied between 0.78 and 4.91 cm. The authors
provided reference values to allow EDX consul-
tants to predict the depth of the diaphragm based
on the patient’s body mass index.105
In the hands of an experienced examiner, ultra-
sound can be used to effectively identify the dia-
phragm and guide the EMG needle away from
nearby viscera.106 Amirjani et al. used ultrasound
visualization of the relevant landmarks in 20
healthy, nonobese subjects and found that the lungs
were less likely to expand into the distal intercostal
space at the anterior axillary line than at the mid-
clavicular line.107 The only scenario with 100% safe-
ty in this study was the right distal intercostal space
at the anterior axillary line in women who were
supine and not breathing deeply. The authors esti-
mated that performing this same procedure in men
would lead to a 10–20% risk of lung tissue interven-
tion. In response to this finding, Podnar and Door-
duin performed ultrasound on 10 healthy men.
They found that the distance between the standard
insertion site recommended by Bolton et al. and the
lung margin was between 7.5 and 17 cm.108 This
study provided evidence that the trans-intercostal
method is likely to be safe in healthy subjects. It is
unknown if pre-existing respiratory disorders, such
as chronic obstructive pulmonary disease, increase
the risk of pneumothorax.
CONCLUSION
In conclusion, by far the most common compli-
cation of EDX studies is pain. Limiting EMG-
related pain has the potential to enhance the diag-
nostic utility of the EDX examination. Among fac-
tors within the control of the EDX consultant, the
choice of muscles to study has the largest effect on
pain. Interventions such as vapocoolant spray or
pre-examination ibuprofen, and techniques such
as finger-slapping, skin-stretching, and minimal
insertion may play a role in further reducing pain.
It is unclear how well these interventions translate
to real-world situations.
EDX consultants should be familiar with the rare
medical complications of needle EMG and nerve
conduction studies. With proper technique and
appropriate precautions, EDX studies are safe in the
general population. Certain patient populations
may be at a greater risk of bleeding, infection, or
cardiac arrhythmia. It is important to recognize
these patients and ensure that the benefits of EDX
testing outweigh the risks prior to proceeding.
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